GLP-1 Receptor Agonist class drugs

3 results

  • ozempic

    (semaglutide)
    Novo Nordisk
    OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events and helps in preventing kidney disease progression in patients with type 2 diabetes and chronic kidney disease.
    Medication Details
    Drug Interactions

  • rybelsus

    (Oral Semaglutide)
    Novo Nordisk
    RYBELSUS is indicated for improving glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise. It is not recommended for patients with type 1 diabetes mellitus.
    Medication Details
    Drug Interactions

  • victoza

    (liraglutide)
    Novo Nordisk
    VICTOZA is indicated to improve glycemic control in adults and pediatric patients (10+) with type 2 diabetes mellitus, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Not for use in type 1 diabetes patients or with other liraglutide products.
    Medication Details
    Drug Interactions